Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets.

Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, Beltran M, Perez-Prados A, Patarroyo ME, Patarroyo MA.

J Virol Methods. 2011 Dec;178(1-2):68-74. doi: 10.1016/j.jviromet.2011.08.014.

PMID:
21884728
2.

Establishment of a molecular diagnostic system for detecting human papillomavirus in clinical samples in Sri Lanka.

Uthayaruban R, Fernandopulle N.

Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1423-30.

PMID:
22299412
3.

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Parra D, Pineda AC, Sussmann O, Perez-Prados A, Patarroyo ME, Patarroyo MA.

PLoS One. 2013;8(2):e56509. doi: 10.1371/journal.pone.0056509.

4.

The diagnostic performance of classical molecular tests used for detecting human papillomavirus.

Munoz M, Camargo M, Soto-De Leon SC, Rojas-Villarraga A, Sanchez R, Jaimes C, Perez-Prados A, Patarroyo ME, Patarroyo MA.

J Virol Methods. 2012 Oct;185(1):32-8. doi: 10.1016/j.jviromet.2012.05.023.

PMID:
22659023
5.

Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples.

Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, Stisser K, Konig R, Tyring SK.

J Virol Methods. 2004 Dec 1;122(1):87-93.

PMID:
15488625
6.

Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Pineda-Peña AC, Perez-Prados A, Patarroyo ME, Patarroyo MA.

J Clin Microbiol. 2013 Nov;51(11):3688-93. doi: 10.1128/JCM.01302-13.

7.

Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens.

Husnjak K, Grce M, Magdić L, Pavelić K.

J Virol Methods. 2000 Aug;88(2):125-34.

PMID:
10960700
8.

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD.

J Clin Microbiol. 1997 Jun;35(6):1304-10.

9.

PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets.

Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kühndel K, Liebert UG.

J Clin Virol. 2004 Aug;30(4):302-8.

PMID:
15163418
10.

High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.

Tanzi E, Bianchi S, Fasolo MM, Frati ER, Mazza F, Martinelli M, Colzani D, Beretta R, Zappa A, Orlando G.

J Med Virol. 2013 Jan;85(1):91-8. doi: 10.1002/jmv.23434.

PMID:
23097252
11.

Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.

Schmitt M, Dondog B, Waterboer T, Pawlita M.

J Clin Microbiol. 2008 Mar;46(3):1050-9. doi: 10.1128/JCM.02227-07.

12.

Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.

Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R.

J Med Virol. 2002 Jun;67(2):246-52.

PMID:
11992586
13.

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM.

J Clin Microbiol. 1997 Mar;35(3):791-5.

14.

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.

Söderlund-Strand A, Carlson J, Dillner J.

J Clin Microbiol. 2009 Mar;47(3):541-6. doi: 10.1128/JCM.02007-08.

15.

Improved amplification of genital human papillomaviruses.

Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ.

J Clin Microbiol. 2000 Jan;38(1):357-61.

16.

GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus.

de Araujo MR, De Marco L, Santos CF, Rubira-Bullen IR, Ronco G, Pennini I, Vizzini L, Merletti F, Gillio-Tos A.

J Clin Virol. 2009 Jun;45(2):90-5. doi: 10.1016/j.jcv.2009.03.020.

PMID:
19447674
17.

Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B.

J Clin Microbiol. 1996 Sep;34(9):2095-100.

18.

Comparative evaluation of the GP5+/6+, MY09/11 and PGMY09/11 primer sets for HPV detection by PCR in oral squamous cell carcinomas.

Erhart SM, Rivero ER, Bazzo ML, Onofre AS.

Exp Mol Pathol. 2016 Feb;100(1):13-6. doi: 10.1016/j.yexmp.2015.11.024.

PMID:
26621496
19.

Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.

Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T.

J Clin Microbiol. 2010 Jan;48(1):143-9. doi: 10.1128/JCM.00991-09.

20.

MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.

Basu P, Chandna P, Bamezai RN, Siddiqi M, Saranath D, Lear A, Ratnam S.

J Clin Microbiol. 2011 Oct;49(10):3537-44. doi: 10.1128/JCM.00354-11.

Items per page

Supplemental Content

Support Center